1. Home
  2. ATRO vs HAE Comparison

ATRO vs HAE Comparison

Compare ATRO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

HOLD

Current Price

$84.31

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$67.26

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRO
HAE
Founded
1968
1971
Country
United States
United States
Employees
2700
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ATRO
HAE
Price
$84.31
$67.26
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$86.00
$84.13
AVG Volume (30 Days)
528.1K
809.4K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$14.92
N/A
Revenue Next Year
$8.81
$5.23
P/E Ratio
N/A
$31.78
Revenue Growth
N/A
N/A
52 Week Low
$27.27
$47.32
52 Week High
$86.27
$87.32

Technical Indicators

Market Signals
Indicator
ATRO
HAE
Relative Strength Index (RSI) 61.27 70.38
Support Level $70.70 $49.26
Resistance Level N/A $86.72
Average True Range (ATR) 4.55 3.39
MACD 0.45 1.31
Stochastic Oscillator 87.43 98.78

Price Performance

Historical Comparison
ATRO
HAE

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: